Cargando…

AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma

Background: Alpha-methylacyl-CoA racemase (AMACR) is a key enzyme responsible for the metabolism of branched-chain fatty acids. It has been found to be an important prognostic factor in numerous types of cancers. This study was aimed to investigate the expression of AMACR and its prognostic signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Hong-Lin, Lee, Ying-En, Chang, Min-Te, Shiue, Yow-Ling, Chang, Shih-Lun, Chen, Tzu-Ju, Chiu, Chang-Ta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930466/ https://www.ncbi.nlm.nih.gov/pubmed/29725255 http://dx.doi.org/10.7150/ijms.23291

Ejemplares similares

AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis
por: Li, Chien-Feng, et al.
Publicado: (2014)

Overexpression of Transient Receptor Protein Cation Channel Subfamily A Member 1, Confers an Independent Prognostic Indicator in Nasopharyngeal Carcinoma
por: Wu, You-Ting, et al.
Publicado: (2016)

The expressions of AMACR and iNOS in prostate adenocarcinomas
por: Ozgur, Tumay, et al.
Publicado: (2013)

Characterization and Prognostic Significance of Methylthioadenosine Phosphorylase Deficiency in Nasopharyngeal Carcinoma
por: He, Hong-Lin, et al.
Publicado: (2015)

Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
por: Alinezhad, Saeid, et al.
Publicado: (2016)

Pseudohyperplastic variant of adenocarcinoma as a component of α-methyl–CoA-racemase (AMACR negative) carcinosarcoma of the prostate
por: Dudani, Sharmila, et al.
Publicado: (2015)

YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma
por: Kuo, Yi-Zih, et al.
Publicado: (2022)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

Selection of aptamers for AMACR detection from DNA libraries with different primers
por: Yang, Deng-Kai, et al.
Publicado: (2018)

Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023)

Correction to: YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma
por: Kuo, Yi-Zih, et al.
Publicado: (2022)

Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma
por: Lin, Yu-Hsuan, et al.
Publicado: (2023)

A study on the AMACR catalysed elimination reaction and its application to inhibitor testing
por: Yevglevskis, Maksims, et al.
Publicado: (2016)

SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Potential impact of ADAM‐10 genetic variants with the clinical features of oral squamous cell carcinoma
por: Chen, Yi‐Tzu, et al.
Publicado: (2023)

CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma
por: Chang, Shih-Lun, et al.
Publicado: (2018)

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma
por: Lee, Hyunji, et al.
Publicado: (2020)

Diagnostic utility of triple antibody (AMACR, HMWCK and P63) stain in prostate neoplasm
por: Rathod, Santosh G., et al.
Publicado: (2019)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Acetyl Coenzyme A Synthase 2 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Cervical Squamous Cell Carcinoma
por: Li, Chia-Jung, et al.
Publicado: (2021)

Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas
por: Chien, Huei-Tzu, et al.
Publicado: (2016)

HOXC6 Overexpression Is Associated With Ki-67 Expression and Poor Survival in NPC Patients
por: Chang, Shih-Lun, et al.
Publicado: (2017)

α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas
por: Aviel-Ronen, Sarit, et al.
Publicado: (2016)

Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?
por: Alston, Erin L. J., et al.
Publicado: (2019)

The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma
por: Hwang, Jau-Chung, et al.
Publicado: (2015)

Prevalence and risk factors for Candida esophagitis among human immunodeficiency virus-negative individuals
por: Chen, Yan-Hua, et al.
Publicado: (2022)

SERPINB5 Expression: Association with CCRT Response and Prognostic Value in Rectal Cancer
por: Chang, I-Wei, et al.
Publicado: (2018)

Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma
por: Wang, Y-F, et al.
Publicado: (2004)

Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature
por: Chen, Shu-Jen, et al.
Publicado: (2015)

The Antimicrobial Effects of Colistin Encapsulated in Chelating Complex Micelles for the Treatment of Multi-Drug-Resistant Gram-Negative Bacteria: A Pharmacokinetic Study
por: Liao, Wei-Chuan, et al.
Publicado: (2023)

CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia
por: Neal, Daniel J., et al.
Publicado: (2020)

Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma
por: Lin, Yu-Hsuan, et al.
Publicado: (2022)

Deletion Hotspots in AMACR Promoter CpG Island Are cis-Regulatory Elements Controlling the Gene Expression in the Colon
por: Zhang, Xiang, et al.
Publicado: (2009)

Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma
por: Dabir, Parag Deepak, et al.
Publicado: (2012)

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2018)

Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
por: de Nóbrega, Monyse, et al.
Publicado: (2020)

Identification of Clinically Significant Prostate Cancer by Combined PCA3 and AMACR mRNA Detection in Urine Samples
por: Kotova, Elena S, et al.
Publicado: (2020)

Utility of AMACR immunohistochemical staining in differentiating Arias-Stella reaction from clear cell carcinoma of ovary and endometrium
por: Nili, Fatemeh, et al.
Publicado: (2023)

Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ
por: Yoo, Daeseon, et al.
Publicado: (2023)

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lpc129nd5m4up1t61j2if21vh4